CD4+CD25+ regulatory T cell repertoire formation shaped by differential presentation of peptides from a self-antigen

Journal of Immunology

Volumn 180, Issue 4, 2008, Pages 2149-2157

  Larkin III, Joseph ^a,c   Rankin, Andrew L ^a   Picca, Cristina Cozzo ^a   Riley, Michael P ^a   Jenks, Scott A ^b   Sant, Andrea J ^b   Caton, Andrew J ^a  

^a WISTAR INSTITUTE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; HEMAGGLUTININ; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYOTONIC DYSTROPHY PROTEIN KINASE; PEPTIDE; POLYPEPTIDE; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; AUTOANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR; VIRUS HEMAGGLUTININ;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CELL DIFFERENTIATION; CELL SURVIVAL; CORRELATION ANALYSIS; DIFFERENTIAL DISPLAY; IMMUNOREACTIVITY; INFLUENZA VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOLECULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; THYMOCYTE; TRANSGENIC MOUSE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; COMPARATIVE STUDY; CYTOLOGY; GENETICS; IMMUNOLOGY; INFLUENZA VIRUS A; L CELL; METABOLISM; MOUSE MUTANT;

ANIMALS; ANTIGEN PRESENTATION; AUTOANTIGENS; CELL DIFFERENTIATION; HEMAGGLUTININS, VIRAL; INFLUENZA A VIRUS; L CELLS (CELL LINE); MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 42149137398     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.4.2149     Document Type: Article

References (41)

1. Shevach, E. M. 2000. Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18: 423-449.
2. Ziegler, S. F. 2006. FOXP3: of mice and men. Annu. Rev. Immunol. 24: 209-226.
3. Tung, K. S., S. S. Agersborg, P. Alard, K. M. Garza, and Y. H. Lou. 2001. Regulatory T-cell, endogenous antigen, and neonatal environment in the prevention and induction of autoimmune disease. Immunol. Rev. 182: 135-148.
4. Seddon, B., and D. Mason. 1999. Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med. 189: 877-882.
5. + regulatory T cells. J. Immunol. 168: 1644-1648.
6. + regulatory T cells in the steady state. J. Exp. Med. 198: 737-746.
7. + T cell receptors. Immunity 21: 267-277.
8. Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3: 756-763.
9. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
10. + regulatory T cells in vivo. J. Exp. Med. 198: 249-258.
11. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA 99: 8213-8218.
12. + T-cell development is regulated by at least 2 distinct mechanisms. Blood 99: 555-560.
13. van Santen, H. M., C. Benoist, and D. Mathis. 2004. Number of Treg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med. 200: 1221-1230.
14. + naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol. 162: 5317-5326.
15. + regulatory T cells express 2 T-cell receptors. Blood 108: 4063-4070.
16. + T cells. Mol. Immunol. 43: 246-254.
17. + T cell responses to a self peptide. Eur. J. Immunol. 30: 136-144.
18. + regulatory T cell suppressor function by analogs of the selecting peptide. Eur. J. Immunol. 37: 139-146.
19. Scott, B., R. Liblau, S. Degermann, L. A. Marconi, L. Ogata, A. J. Caton, H. O. McDevitt, and D. Lo. 1994. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1: 73-83.
20. Gerhard, W., A. M. Haberman, P. A. Scherle, A. H. Taylor, G. Palladino, and A. J. Caton. 1991. Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. J. Virol. 65: 364-372.
21. Mombaerts, P., A. R. Clarke, M. A. Rudnicki, J. Iacomini, S. Itohara, J. J. Lafaille, L. Wang, Y. Ichikawa, R. Jaenisch, M. L. Hooper, and S. Tonegawa. 1992. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 360: 225-231.
22. Fazekas de St. Groth, S., and R. G. Webster. 1966. Disquisitions on original antigenic sin: I. Evidence in man. J. Exp. Med. 124: 331-345.
23. + single positive cells with a class II major histocompatibility complex-restricted receptor. J. Exp. Med. 180: 25-34.
24. Wells, A. D., H. Gudmundsdottir, and L. A. Turka. 1997. Following the fate of individual T cells throughout activation and clonal expansion: signals from T cell receptor and CD28 differentially regulate the induction and duration of a proliferative response. J. Clin. Invest. 100: 3173-3183.
25. Katz, J. F., C. Stebbins, E. Appella, and A. J. Sant. 1996. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules. J. Exp. Med. 184: 1747-1753.
26. Stebbins, C. C., M. E. Peterson, W. M. Suh, and A. J. Sant. 1996. DM-mediated release of a naturally occurring invariant chain degradation intermediate from MHC class II molecules. J. Immunol. 157: 4892-4898.
27. Nanda, N. K., and A. J. Sant. 2000. DM determines the cryptic and immunodominant fate of T cell epitopes. J. Exp. Med. 192: 781-788.
28. + regulatory T cells. Nat. Immunol. 4: 330-336.
29. Fontenot, J. D., J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Developmental regulation of Foxp3 expression during ontogeny. J. Exp. Med. 202: 901-906.
30. Fontenot, J. D., J. P. Rasmussen, L. M. Williams, J. L. Dooley, A. G. Farr, and A. Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor Foxp3. Immunity 22: 329-341.
31. + regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J. Immunol. 173: 236-244.
32. Shih, F. F., D. M. Cerasoli, and A. J. Caton. 1997. A major T cell determinant from the influenza virus hemagglutinin (HA) can be a cryptic self peptide in HA transgenic mice. Int. Immunol. 9: 249-261.
33. + T cells. J. Immunol. 165: 4870-4876.
34. Malissen, M., J. Trucy, E. Jouvin-Marche, P. A. Cazenave, R. Scollay, and B. Malissen. 1992. Regulation of TCR alpha and beta gene allelic exclusion during T-cell development. Immunol. Today 13: 315-322.
35. Alt, F. W., E. M. Oltz, F. Young, J. Gorman, G. Taccioli, and J. Chen. 1992. VDJ recombination. Immunol. Today 13: 306-314.
36. Yuan, Q., S. K. Bromley, T. K. Means, K. J. Jones, F. Hayashi, A. K. Bhan, and A. D. Luster. 2007. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204: 1327-1344.
37. Villarino, A. V., J. Larkin, III, C. J. Saris, A. J. Caton, S. Lucas, T. Wong, F. J. de Sauvage, and C. A. Hunter. 2005. Positive and negative regulation of the IL-27 receptor during lymphoid cell activation. J. Immunol. 174: 7684-7691.
38. Hsieh, C. S., Y. Zheng, Y. Liang, J. D. Fontenot, and A. Y. Rudensky. 2006. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires. Nat. Immunol. 7: 401-410.
39. Lazarski, C. A., F. A. Chaves, and A. J. Sant. 2006. The impact of DM on MHC class II-restricted antigen presentation can be altered by manipulation of MHC-peptide kinetic stability. J. Exp. Med. 203: 1319-1428.
40. Sant, A. J., F. A. Chaves, S. A. Jenks, K. A. Richards, P. Menges, J. M. Weaver, and C. A. Lazarski. 2005. The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes. Immunol. Rev. 207: 261-278.
41. Eisenlohr, L. C., W. Gerhard, and C. J. Hackett. 1988. Individual class II-restricted antigenic determinants of the same protein exhibit distinct kinetics of appearance and persistence on antigen-presenting cells. J. Immunol. 141: 2581-2584.